Nucleic acid therapeutics in cancer /

Bibliographic Details
Other Authors: Gewirtz, A. M. (Alan M.)
Format: Book
Language:English
Published: Totowa, N.J. : Humana Press, [2004]
Series:Cancer drug discovery and development.
Subjects:
Table of Contents:
  • Antisense methodology / Fritz Eckstein
  • Nucleic acid therapeutics / Alan M. Gewirtz
  • Targeted genome modification via triple helix formation / Faye A. Rogers and Peter M. Glazer
  • Therapeutic applications of ribozymes / John J. Rossi
  • Use of catalytic DNA in target validation and therapeutics / Lun-Quan Sun
  • Targeted destruction of small, stable RNAs / David A. Dunbar and Susan J. Baserga
  • Mechanism of action of antisense RNA in eukaryotic cells / Zuo Zhang and Gordon G. Carmichael
  • The transport of oligonucleotides into cells / R.L. Juliano
  • Peptide-mediated delivery of antisense oligonucleotides and related material / Eric VivĂ„s, Jean Philippe Richard and Bernard Lebleu
  • Molecular vectors for gene delivery to cancer cells / Guy Zuber ... [et al.]
  • Considerations on the design of antisense oligonucleotides / Rosel Kretschmer-Kazemi Far, Jens Warnecke and Georg Sczakiel
  • Identification of hybridization accessible sequence in messenger RNA / Lida K. Gifford, Ponzy Lu, and Alan M. Gewirtz
  • Nucleic acids as gene targeting therapeutics / Joanna B. Opalinska and Susan E. Shetzline
  • LY900003 (Isis 3521) and G3139 (Genasense; Oblimersen) / C.A. Stein ... [et al.]
  • Antisense protein kinase A-RI restores normal signal transduction signatures to inhibit tumor growth / Yoon S. Cho-Chung.